Cite
HARVARD Citation
Zannad, F. et al. (2015). Heart failure and mortality outcomes in patients with type 2 diabetes taking alogliptin versus placebo in EXAMINE: a multicentre, randomised, double-blind trial. Lancet. 385 (9982), pp. 2067-2076. [Online].